Notably, mutations in the BRAF, NRAS, and p53 genes are commonly observed in melanoma, driving unregulated cell proliferation, resistance to programmed cell death, and the eventual development of malignant tumors (27–31). The gene discussed is NRAS; the disease is melanoma.